During the past decade, Barbara Rewerska DIAMOND CLINIC conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 5 clinical trials were completed, i.e. on average, 55.6% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 5 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Barbara Rewerska DIAMOND CLINIC" #1 collaborator was "Incyte Corporation" with 3 trials as a collaborator and "Syneos Health" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Barbara Rewerska DIAMOND CLINIC" are "Atopic Dermatitis" (3 trials), "Psoriasis" (2 trials), "Allergy" (1 trials), "Palmoplantar Pustulosis" (1 trials) and "Palmoplantar Pustulosis (PPP)" (1 trials). Many other conditions were trialed in "Barbara Rewerska DIAMOND CLINIC" in a lesser frequency.

Most popular intervention types in "Barbara Rewerska DIAMOND CLINIC" are "Drug" (9 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Baricitinib" (3 trials), "ABP 654" (2 trials), "Spesolimab" (2 trials) and "Ustekinumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Barbara Rewerska DIAMOND CLINIC" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Barbara Rewerska DIAMOND CLINIC". undefined are not yet recruiting, undefined are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Barbara Rewerska DIAMOND CLINIC, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Barbara Rewerska DIAMOND CLINIC, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".